SAREPTA THERAPEUTICS, INC.
Patent Owner
Stats
- 46 US PATENTS IN FORCE
- 8 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 46 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,887 Total Citation Count
- Aug 05, 2004 Earliest Filing
- 17 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0016,574 EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHYFeb 13, 17Jan 18, 18[A61K, C12N]
2017/0369,876 EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHYFeb 01, 17Dec 28, 17[A61K, C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9833468 Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNAMar 29, 16Dec 05, 17[A61K, C12N]
9790499 Functionally-modified oligonucleotides and subunits thereofJan 26, 16Oct 17, 17[C07H, C07F, C12N]
9469664 Oligonucleotide analogues having modified intersubunit linkages and/or terminal groupsJun 06, 14Oct 18, 16[C07H, A61K, C07F, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0298,111 EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHYAbandonedNov 16, 15Oct 13, 16[A61K, C12N]
2015/0361,428 EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHYAbandonedJun 18, 15Dec 17, 15[C12N]
2015/0344,884 INHIBITORY OLIGONUCLEOTIDES AND THEIR USE IN THERAPYAbandonedJan 13, 14Dec 03, 15[C12N]
2015/0197,534 ANTISENSE-INDUCED EXON2 INCLUSION IN ACID ALPHA-GLUCOSIDASEAbandonedSep 05, 14Jul 16, 15[C07F]
2014/0329,881 EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHYAbandonedMar 14, 14Nov 06, 14[C12N]
2014/0315,977 EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHYAbandonedMar 14, 14Oct 23, 14[C12N]
2014/0287,983 ANTISENSE COMPOSITIONS AND METHODS FOR MODULATING CONTACT HYPERSENSITIVITY OR CONTACT DERMATITISAbandonedOct 25, 13Sep 25, 14[A61K, C12N]
8618270 Oligonucleotide analog and method for treating flavivirus infectionsExpiredAug 02, 10Dec 31, 13[A61K, C07H, C12N]
8524676 Method for treating enterovirus or rhinovirus infection using antisense antiviral compoundsExpiredSep 08, 06Sep 03, 13[A61K, C07H, C12N]
2010/0016,215 COMPOUND AND METHOD FOR TREATING MYOTONIC DYSTROPHYAbandonedJun 26, 09Jan 21, 10[A61K, A61P, C07K]
2005/0288,246 Peptide conjugated, inosine-substituted antisense oligomer compound and methodAbandonedMay 23, 05Dec 29, 05[A61K, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.